Questcor is a specialty pharmaceutical company focused on providing prescription
drugs for central nervous system (CNS) disorders. We are presently building
a core portfolio of both marketed and development-stage products that address
significant unmet medical needs. We will seek to develop and commercialize
our own proprietary products, and are open to a range of partnering concepts
in order to leverage our assets and build our portfolio.
We have a highly experienced sales and marketing team focused on growing our currently marketed neurology product. In addition, we are actively looking for acquisition, licensing, development and partnering opportunities within the CNS field to further build our CNS portfolio and maximize our long term growth.
7/24/2008 4:07:00 PM - Questcor Reports Second Quarter Results
Global Hunter Securities has initiated coverage of the company